HOMA-IR 2.5 — the insulin-resistance number your doctor probably skipped
HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) is a simple calculated index derived from fasting glucose and fasting insulin: (fasting glucose mmol/L × fasting insulin µIU/mL) / 22.5. A HOMA-IR of 2.5 sits at the threshold most metabolic research uses for early insulin resistance — values below ~1.5 are typically considered insulin-sensitive, 1.5–2.5 borderline, and ≥2.5 indicative of meaningful insulin resistance. Crucially, HOMA-IR can rise years before HbA1c moves out of normal range, making it a much earlier warning signal for the metabolic-syndrome trajectory than a routine GP panel typically captures.
Reference ranges
| Insulin-sensitive | < 1.5 |
| Borderline | 1.5 – 2.5 |
| Insulin resistant | 2.5 – 5.0 |
| Severely insulin resistant | > 5.0 |
What this marker measures
HOMA-IR estimates insulin resistance from a single fasting blood draw. The underlying physiology: in healthy people, fasting insulin is low (typically <8 µIU/mL) because tissues are sensitive to it. As tissues become resistant, the pancreas compensates by secreting more insulin to keep glucose in range — fasting insulin rises while fasting glucose stays normal. HOMA-IR multiplies the two and so captures this compensation phase before glucose itself drifts up. The classic HOMA-IR validation study against gold-standard euglycaemic clamps showed correlation of 0.85+ across populations.
Why might it be elevated?
- ·Visceral adiposity (waist circumference is a strong predictor)
- ·Sedentary lifestyle — exercise sensitises muscle to insulin within days
- ·Diet pattern: high refined carbohydrate, low fibre
- ·Sleep deprivation — even one week of restricted sleep raises HOMA-IR
- ·Cortisol elevation (chronic stress, glucocorticoid medication)
- ·PCOS in women
- ·Genetic predisposition — family history of type 2 diabetes
Why might it be low?
- ·Athletic training, particularly resistance training
- ·Caloric restriction or fasting
- ·Pharmacological insulin sensitisation (metformin, GLP-1 agonists)
- ·Hyperthyroidism (rare — usually transient)
Compounds whose research literature has investigated this area
These are research-grade compounds in our catalogue whose published study literature touches the same biology. Listed for research context — not as recommendations for self-administration.
Retatrutide is a triple agonist at the GLP-1, GIP, and glucagon receptors. The 40 mg pen is the highest-dose presentation in the Omega Grade catalogue — pre-reconstituted for researchers running extended protocols.
Cagrilintide is a long-acting amylin analogue most widely investigated in combination with semaglutide under the CagriSema programme. Commonly stacked with GLP-1 receptor agonists in preclinical research.
MOTS-c is a 16-residue peptide encoded in the mitochondrial 12S rRNA region. Described by the Cohen lab in 2015 — studied in metabolic and exercise biology.
Tesamorelin is an approved GHRH analogue. The research-grade form is used widely in GH-axis, lipid-metabolism, and hepatic-fat research.
FAQ
Is HOMA-IR 2.5 prediabetic?+
Not by formal HbA1c criteria, but research literature consistently shows HOMA-IR rising years before HbA1c reaches the 5.7% prediabetic threshold. A reading of 2.5 indicates compensated insulin resistance — tissues are less responsive but the pancreas is still keeping glucose normal.
How do I lower it?+
The most reliable lifestyle interventions in randomised trials: reducing visceral adiposity (5–10% body weight loss), adding resistance training, prioritising sleep, and reducing refined-carbohydrate intake. Pharmacological options exist but are typically gated behind a formal diabetes or PCOS diagnosis.
How often should I retest?+
Every 3–6 months if you're actively intervening. Same time of day, fasted (12+ hours), no exercise the day before — fasting insulin is sensitive to all of these.
This page describes biomarker research and reference ranges for self-tracking and research-context discussion only. It is not medical advice, not a diagnosis, and not a substitute for a qualified physician. Take any concerns about your health to a clinician.
Have your own panel? Read it next to the standard reference ranges with our free analyse tool.
Analyse my blood work →